Engineering Biology Readiness Act
- Bill Number
- S. 4363
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Policy Area
- Government Operations and Politics
- Status
- Introduced
- Latest Action
- 2026-04-21: Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
- Last Updated
- 2026-05-04T21:41:13Z
AI-Generated Summary
Purpose
The Engineering Biology Readiness Act (S. 4363) aims to strengthen U.S. biodefense by extending requirements for annual congressional briefings on the National Biodefense Strategy and mandating a specific analysis and recommendations on risks from engineering biology (advanced techniques like gene editing or synthetic biology that could create harmful biological agents).
Key Provisions
- Short Title: "Engineering Biology Readiness Act."
- Extension of Briefings (Sec. 2): Amends the National Defense Authorization Act for Fiscal Year 2017 to extend annual briefings on the National Biodefense Strategy from March 1, 2025, to five years after enactment of the National Defense Authorization Act for Fiscal Year 2027.
- Analysis and Recommendations on Engineering Biology Risks (Sec. 3):
- Requires inclusion in the next biennial biodefense threat assessment update (under the 2021 NDAA).
- Analysis covers:
- Threats to national security and public safety from engineering biology risks (misuse, abuse, or accidental release of engineered materials, methods, tools, or information).
- Current research and development (R&D) in prevention, detection, response, etc.
- Existing U.S. authorities, regulations, and programs on biosafety (lab safety), biosecurity (preventing theft/misuse), and biodefense.
- Gaps, overlaps, or unclear areas in these rules.
- Recommendations include:
- Aligning R&D across agencies to avoid duplication.
- Updating rules and programs to mitigate risks while supporting innovation.
- Creating or updating programs for safeguards, best practices, and guidance on biosecurity/biosafety.
- Proposed laws and funding estimates.
- Developed with input from industry, academia, civil society (including non-federally funded researchers), and others.
- Submitted unclassified, with optional classified annex.
- Defines key terms like "covered departments and agencies" (e.g., DHS, DoD, HHS—per 2021 NDAA), "engineering biology," and "engineering biology risk."
Significant Changes to Existing Law
- Extends Briefing Deadline: Pushes annual National Biodefense Strategy briefings beyond 2025, tying it to a future NDAA.
- New Requirements in Biennial Assessment: Adds mandatory focus on engineering biology risks to the existing biennial biodefense threat update process, including detailed analysis, recommendations, and stakeholder consultation—previously not specified.
Potential Impacts
- Government Agencies: Increases coordination among agencies on R&D and policy; may lead to new programs, updated regulations, and resource requests for biodefense.
- Citizens and Public Safety: Enhances preparedness against engineered bio-threats, potentially reducing risks from accidents or attacks.
- Research and Innovation: Promotes safer life sciences research with governance frameworks, balancing security and benefits from new technologies.
- No Direct International Impact Noted: Focuses on domestic readiness, though improved biodefense could indirectly strengthen global posture.
Main Stakeholders Affected
- Federal Agencies: "Covered departments and agencies" (e.g., Homeland Security, Defense, Health and Human Services) responsible for analysis and implementation.
- Congress: Receives extended briefings and enhanced threat assessments.
- Life Sciences Sector: Industry, academia, and researchers (including independent voices) consulted on recommendations; subject to potential new safeguards.
- Civil Society: Involved in consultations; benefits from mitigated public safety risks.
Notable Legal, Constitutional, or Political Implications
- Legal: Builds on existing NDAA frameworks without creating new agencies; proposes legislative actions for future laws, emphasizing voluntary guidance over mandates.
- Constitutional: Aligns with Congress's oversight role in national security and funding appropriations.
- Political: Bipartisan (introduced by Sens. Kaine and Budd); signals priority on emerging biotech threats amid rapid advances in synthetic biology, potentially influencing future defense budgets and regulations.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2026-04-21: Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
- 2026-04-21: Introduced in Senate
Bill Versions
- Engineering Biology Readiness Act — issued 2026-04-21 — PDF (6 pages)